By contrast, TIM-1-/- mice challenged with the same dose had significantly reduced mortality following EBOV GP/rVSV or EBOV GPΔO/rVSV infection and delayed time-to-death of those that did succumb to infection. The gene discussed is HAVCR1; the disease is infection.